Mechanical Dyssynchrony and Microvascular Dysfunction by SPECT
NCT06969547 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 75
Last updated 2025-09-24
Summary
The project is aimed at studying the feasibility of mechanical dyssynchrony of the left ventricle of the heart, determined by SPECT (gated MPI), as well as its stress-induced dynamics, in the evaluation of patients with coronary microvascular dysfunction in chronic coronary heart diseasу.
Conditions
- Myocardial Blood Flow Reserve
- Mechanical Dyssynchrony
- Coronary Arterial Disease (CAD)
Interventions
- DIAGNOSTIC_TEST
-
dynamic SPECT (two-day rest/stress protocol)
All nuclear examinations will be performed using a hybrid specialized SPECT/CT Discovery NM/CT570C. At the first stage the passage of the bolus of the radiopharmaceutical through the chambers and the LV myocardium will be recorded at rest. Through a pre-installed intravenous catheter, a bolus of the radiopharmaceutical in a volume of 5 ml (370 MBq) will be injected at a rate of 0,5 ml/sec, after which 30 ml of saline will be injected at a rate of 2 ml/sec. Data acquisition will begin immediately before the introduction of the radiopharmaceutical. Registration of dynamic images will be performed in the "List Mode". At the second day stress test study will be performed (ATP at a dosage of 160 mcg/kg/min over 4 minutes). The bolus volume of the radiopharmaceutical, saline and the rate are equal to the study at rest. The time of data collection at each stage of the study will be 12 minutes. The introduction of the radiopharmaceutical will be performed at 2 minutes of the stress test.
- DIAGNOSTIC_TEST
-
gated myocardial perfusion imaging
Gated MPI will be performed according to a two-day rest-stress protocol. For both stress and rest studies, the acquisition will be performed 60 minutes after the dynamic SPECT. The recording time will be 5 minutes. To correct the attenuation, a low-dose CT scan of the chest, obtained earlier with dynamic recording, will be used. The voltage on the X-ray tube will be 120 kV, the current strength will be 20 mA; tube rotation time 0.8 s; pitch 0.969:1. Radiopharmaceutical administration will be performed only once a day during dynamic SPECT. Immediately after recording the gMPI at rest, the patient will undergo a series of sequential injections of dobutamine at doses of 5 and 10 µg/kg/min with simultaneous recording. The duration of data collection on each dose of dobutamine will be 5 minutes.
- OTHER
-
blood sampling
Indicators of: * endothelial dysfunction (specific endothelial cell molecule 1 (endocan, ESM1), endotelin-1) * severity of inflammatory response (tumor necrosis factor (TNF-α), interleukin-6 (IL-6)) * myocardial fibrosis (matrix metalloproteinase (MMP-9) * myocardial dysfunction (NT-proBNP)
- DIAGNOSTIC_TEST
-
Low Dose CT-scan
Scanning parameters: tube voltage 120 kV; current 435 mA; tube rotation time 0.4 s; slice thickness 2.5 mm; interslice interval 2.5 mm.
- DIAGNOSTIC_TEST
-
CT-coronary angiography
The study will be performed on a 64-slice GE Discovery NM/CT 570С (GE Healthcare, Milwaukee, WI, USA) from the level of the tracheal bifurcation to the diaphragm during breath holding (6-8 s) in the prospective (for HR≤55) or retrospective (for HR\>55) ECG-synchronized mode. To contrast coronary arteries, it is planned to use an intravenous infusion of 85-90 ml (at a rate of 5 ml/s) of an iodine-containing (370 mg iodine/ml) radiopaque substance.Scan will be performed with the following parameters: current strength 120 kV; voltage 300-600 mA with ECG modulation; tube rotation speed 0.4 s; pitch: 0.18-0.22 (depending on heart rate).
Sponsors & Collaborators
-
Russian Science Foundation
collaborator OTHER -
Tomsk National Research Medical Center of the Russian Academy of Sciences
lead OTHER
Principal Investigators
-
Vladimir V Shipulin, MD, PhD · Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-10-01
- Primary Completion
- 2025-05-15
- Completion
- 2026-05-15
Countries
- Russia
Study Locations
More Related Trials
-
Evaluation of the Diagnostic Performance of Dynamic Myocardial Perfusion Scintigraphy in Comparison With Invasive Intracoronary FFR Measurement, in the Assessment of Significant Residual Coronary Stenosis After Acute Coronary Syndrome: Dyna-MI Pilot Study.
NCT05940285 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluating Microvascular Dysfunction in Symptomatic Patients With HypertroPhic CaRdiomyopathy
NCT02994615 ·Status: COMPLETED
-
Multi-Center Evaluation of Feasibility of SPECT Measurement of Myocardial Blood Flow and Reserve
NCT03427749 ·Status: COMPLETED
-
Cardiac Structure, Function, and Clinical Manifestations in MINOCA
NCT03572023 ·Status: COMPLETED ·Phase: NA
-
Phase 3 Imaging and Safety Study of AI-700 in Patients With Suspected Coronary Artery Disease Undergoing SPECT Imaging
NCT00156793 ·Status: COMPLETED ·Phase: PHASE3
-
Perfusion Imaging With Myocardial Contrast Echocardiography in HCM
NCT02560467 ·Status: UNKNOWN ·Phase: NA
-
xSPECT-based Myocardial Perfusion Scintigraphy: Consistency of Functional Values and Feasibility of Myocardial Uptake Quantitation in Patients With Suspected Coronary Artery Disease
NCT04583787 ·Status: COMPLETED ·Phase: NA
-
Diagnostic Accuracy Of Seismocardiography for Coronary Artery Disease
NCT06880120 ·Status: COMPLETED ·Phase: NA
-
Dynamic CT Myocardial Perfusion Imaging
NCT02593838 ·Status: TERMINATED ·Phase: NA
-
SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
NCT06030596 ·Status: UNKNOWN
-
Myocardial Flow Reserve and 99mTc-DTPA Cardiac Dynamic SPECT
NCT02844686 ·Status: UNKNOWN ·Phase: NA
-
Impact of Stress CT Myocardial Perfusion on Downstream Resources and Prognosis
NCT03976921 ·Status: UNKNOWN ·Phase: NA
-
Meta-Analysis of Stress Myocardial Perfusion Imaging
NCT03180060 ·Status: COMPLETED
-
A Head-to-Head Comparison of A New Perfusion Tracer, 99mTc-4BOH vs. 13N-NH3 to Evaluate Diagnostic Efficacy of Ischemic Heart Disease
NCT06980194 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Comparison Between Myocardial Tomoscintigraphies Using a Semiconductor Camera or a Conventional Camera
NCT02861235 ·Status: COMPLETED ·Phase: NA
-
Validation of a Single Rest-Stress Imaging Protocol for Myocardial Perfusion Imaging
NCT03265535 ·Status: UNKNOWN
-
Prognostic Value of Stress SPECT Myocardial Perfusion Imaging With Half Dose 99mTc-Tetrofosmin
NCT02019212 ·Status: COMPLETED
-
Cadmium-zinc-telluride (CZT) Imaging of Myocardial Blood Flow (MBF) (SPECT MBF)
NCT02280941 ·Status: COMPLETED ·Phase: NA
-
Role of Stress CMR in Predicting Adverse Clinical Events in Patients With Known or Suspected IHD
NCT01821924 ·Status: COMPLETED
-
Evaluation of the Functional Impact of Coronary Stenoses in Diabetics by Spectral CT
NCT05471687 ·Status: UNKNOWN ·Phase: NA
-
Intracardiac Flow Assessment in Cardiac Amyloidosis
NCT05379101 ·Status: RECRUITING
-
Effectiveness Study of Single Photon Emission Computed Tomography (SPECT) Versus Positron Emission Tomography (PET) Myocardial Perfusion Imaging
NCT00976053 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Diagnostic Rest/Stress SPECT Results for Patients With Myocardial Ischemia and Infarction Using Myoview in Both Single and Dual Isotope Acquisition Approaches
NCT00381316 ·Status: COMPLETED ·Phase: PHASE4
-
Combined Non-invasive Coronary Angiography and Myocardial Perfusion Imaging Using 320 Detector Computed Tomography
NCT00934037 ·Status: COMPLETED ·Phase: PHASE3
-
Dynamic Cardiac SPECT Imaging
NCT01934985 ·Status: COMPLETED